Mainz, Germany

Uwe Pschorn

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.7

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Uwe Pschorn: A Pioneer in Pharmaceutical Innovations

Introduction: Uwe Pschorn, an accomplished inventor based in Mainz, Germany, is known for his contributions to the pharmaceutical field. With a portfolio of four patents, he has made significant strides in developing innovative compounds that hold potential in medical applications.

Latest Patents: Among Uwe Pschorn's notable patents are promising chemical compounds aimed at enhancing therapeutic efficacy. His latest inventions include the patent for "1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ols." Furthermore, he has developed substituted "3-phenoxy- and 3-phenylalkyloxy-2-phenyl-propylamines." This patent application details new substituted compounds of general formula 1, processes for their preparation, and their uses as pharmaceutical compositions.

Career Highlights: Uwe Pschorn has had a notable career, having worked with Boehringer Ingelheim Pharma KG and Boehringer Ingelheim KG. His experience in these prestigious companies has undoubtedly contributed to his innovative work and the successful development of his patented inventions.

Collaborations: Throughout his career, Uwe Pschorn has collaborated with several esteemed colleagues, including Thomas Weiser and Rainer Palluk. These professional relationships have likely fostered an environment of creativity and innovation that is essential in the field of pharmaceutical research.

Conclusion: Uwe Pschorn's contributions to the pharmaceutical industry through his patents and collaborative efforts highlight the importance of innovation in healthcare. His work continues to pave the way for new therapeutic options, illustrating the vital role of inventors in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…